26 October 2020
  • 5:02 pm Iran’s parliament lashes out at Macron over Islamophobic remarks
  • 5:02 pm China to impose sanctions on U.S. firms over Taiwan arms sales
  • 4:48 pm Salman Butt reveals reasons behind retirement from red-ball cricket
  • 4:47 pm Stock rally, rupee appreciation point to ‘positive economic sentiment’: Azhar
  • 4:47 pm WhatsApp will not be free for all anymore
Choose Language
 Edit Translation
My-Ads
Spread the News

After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian Covid-19 vaccine Sputnik V, the company and Russia’s sovereign wealth fund Russian Direct Investment Fund (RDIF) have now received the Drug Control General of India (DCGI) nod to conduct an adaptive Phase 2/3 human clinical trial for the Russian vaccine in India.

Abdul Gh Lone

RELATED ARTICLES